Nanoparticles containing anti-cancer drug – A review
DOI:
https://doi.org/10.26452/ijcpms.v3i4.558Keywords:
Nanoparticles, Anti-Cancer, Paclitaxel, MelanomaAbstract
These day throughout medicine and science as well as investigates, melanoma is among the most threating illness even though sadly now still we've neither medical care regarding purchasing of this illness. There have been multiple strategies regarding cancer therapy utilizing nanoparticles such as targeted as well as non-targeted nanoparticles. Various studies demonstrate that adverse reactions like doxorubicin (an anti - cancer drug) could be reducing through nanotechnology, that also decrease this same multi - drug resistant. Camptothecin loaded Nanoparticles demonstrate prolonged plasma retention, elevated as well as prolonged tumour location. Nano-particles ready besides poly-lactic-co-glycoside rise a half-life of cisplatin. Recent innovation through Nanoparticle-based common therapeutic have also shown some many distinguishing characteristics which are unworkable out conventional chemotherapy. Drug mixtures can be optimized and cunningly presented in this more wise investment.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 International Journal of Clinical Pharmacokinetics and Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.